Biohaven enrolls first patient in oral zavegepant study in migraine, secures $100M milestone
March 29 2021 - 6:44AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Biohaven (NYSE:BHVN)
Historical Stock Chart
From Apr 2024 to May 2024
Biohaven (NYSE:BHVN)
Historical Stock Chart
From May 2023 to May 2024